InsidersTradesSigma
Follow the 药易购 stock price and the full directors' dealings record of the company, a listed equity based in China. Shares trade on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 药易购 has published 9 public disclosures. Market capitalisation: €2.2bn. The latest transaction was filed on 3 July 2025 (Sale). Among the most active insiders: 田文书. All data is free.
9
Insider Decl.
n/a
Thresholds
€5,005
1 ops.
Buy Volume
€6m
8 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,718 of 29,064 companies
19.7
score / 100
Value22
Quality18
FCF yld-0.9%
Earn yld-0.6%
EV/EBITDA55.8x
ROE-2.4%
Gross mgn10%
Net mgn-0.3%
Debt/EBITDA7.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 3 July 2025
Declarations9 total
9 of 9 declarations
关于 药易购
药易购是一家在XSHE市场上市的医疗保健和制药领域的公司。它专注于药品在线销售。